United Orthopedic (ROCO:4129) Research & Development: NT$263 Mil (TTM As of Dec. 2025)


ROCO:4129 United Orthopedic Corp ROCO:4129
81 GF Score
Price NT$91.70
GF Value NT$123.70
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is United Orthopedic Research & Development?

United Orthopedic ROCO:4129 +0.55% 81 Research & Development is NT$263 Mil as of Dec. 2025. GuruFocus rates ROCO:4129 with a GF Score™ of 81/100 and a GF Value™ of NT$123.70 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. United Orthopedic's Research & Development for the three months ended in Dec. 2025 was NT$73 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$263 Mil.

United Orthopedic  (ROCO:4129) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

United Orthopedic Research & Development Related Terms

United Orthopedic Research & Development Historical Data

* Premium members only.

The historical data trend for United Orthopedic's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

United Orthopedic Research & Development Chart

United Orthopedic Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 143.68 167.26 185.03 220.49 262.54

United Orthopedic Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.45 59.98 63.52 66.34 72.70
ROCO:4129
81GF Score
United Orthopedic Corp ROCO:4129
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

United Orthopedic Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$263 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$263 Mil mean?
United Orthopedic (ROCO:4129) has a Research & Development of NT$263 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on United Orthopedic and its competitors.
Is United Orthopedic's Research & Development too high?
United Orthopedic's current Research & Development is NT$263 Mil. Overall, United Orthopedic has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does United Orthopedic's Research & Development compare to ABT and SYK?
United Orthopedic's Research & Development of NT$263 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on United Orthopedic and its competitors. United Orthopedic's current Research & Development is NT$263 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Orthopedic stock overvalued right now?
Based on GuruFocus' analysis, United Orthopedic (ROCO:4129) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$123.70, compared to a current price of NT$91.70 — trading 25.9% below its estimated fair value. The current Research & Development is NT$263 Mil. United Orthopedic's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For United Orthopedic (ROCO:4129), the current Research & Development is NT$263 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is United Orthopedic (ROCO:4129) Overvalued in 2026?

Based on GuruFocus' analysis, United Orthopedic stock appears to be undervalued. The current stock price of NT$91.70 is trading 25.9% below its estimated GF Value™ of NT$123.70. GuruFocus considers United Orthopedic to be Modestly Undervalued.

Key valuation signals for ROCO:4129:

  • Research & Development: NT$263 Mil
  • GF Value™: NT$123.70 vs. price of NT$91.70 (25.9% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the ROCO:4129 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

United Orthopedic Business Description

Address 12th Floor, No.80, Section 1, Chenggong Road, Yonghe District, New Taipei City, TWN, 234634
United Orthopedic Corp is engaged in the research, development, production, manufacturing, and sales of orthopedic implants, orthopedic surgical instruments and manufacturing equipment, special metal and plastics materials, as well as the import and export of the aforementioned products. Its products include Hip System, Knee System, and Limb Salvage.
81GF Score

Get the complete analysis for ROCO:4129

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$91.70
Price
NT$123.70
GF Value